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ABSTRACT
Recent studies have shown that nanoparticles, which are
approximately 1 to 100 billionths of a meter in size, present
unique health and environmental risks. Nevertheless, products
enhanced by nanoparticles, such as sunscreen, golf balls, and
hard drives, are shipped daily in international trade. With these
unique risks in mind, would measures regulating the trade in
nanotechnology be subject to the WTO Agreement on Sanitary
and Phytosanitary Measures?
If they were, would the
Agreement objectively balance the unique risks and benefits of
trading in nanotechnology? Whether measures regulating the
trade in nanotechnology are subject to the SPS Agreement
depends on the purpose of such measures. This iBrief argues
that because of recent scientific evidence, many such measures
are likely to be subject to the SPS Agreement. In addition, since
sanitary and phytosanitary measures must be based on scientific
evidence, if Members apply the Agreement appropriately, the
Agreement would objectively balance the benefits and risks of
trading in nanotechnology.

INTRODUCTION
Despite all the hype regarding nanotechnology’s commercial
potential, defining nanotechnology is difficult.
Nanotechnology
originally meant molecular manufacturing but now encompasses a broad
range of science and technology at the nanoscale,2 which is
approximately 1 to 100 billionths of a meter.3 Molecular manufacturing,
crudely defined, is the ability to create anything molecule-by-molecule.4
Although manufacturing at this level is currently far from feasible, one
¶1
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area where nanotechnology is used today is to enhance products. In fact,
products enhanced by nanoparticles are used daily by millions of people
throughout the world. Such products include sunscreens, cosmetics,
tennis balls, stain-free clothing and mattresses, and hard drives.5
¶2
Even though nanoparticles enhance products, recent scientific
studies have shown that nanoparticles present unique and significant
health risks. For example, nanoparticles are small enough to pass
through the blood-brain barrier in fish.6 It follows that overexposure of
nanoparticles to humans may lead to the accumulation of lethal quantities
of nanomaterial in the brain much like asbestos accumulates in the
lungs.7
¶3
Such potential health risks raise questions about how the
international community should regulate trade in nanotechnology. It
took the international community almost 100 years to establish
regulations for asbestos.8 How long will it take for nanotechnology?
Perhaps current international health and safety standards are already
applicable to measures regulating trade in this new technology. If so, are
they capable of balancing the unique risks and benefits of trading in
nanotechnology? Or, are new international standards necessary? In
addressing these issues, this iBrief analyzes the WTO Agreement on the
Application of Sanitary and Phytosanitary Measures (“SPS
Agreement”).9 It will also look at relevant WTO disputes, the most
important being EC Measures Concerning Meat and Meat Products
(“Hormone Beef”), the first WTO dispute to substantively deal with the
SPS Agreement.10
¶4
Like any trade protective measure, whether the SPS Agreement
applies to measures prohibiting trade in nanotechnology depends on the
measure’s purpose.11 The SPS Agreement applies to sanitary and
5
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phytosanitary measures (”SPS measures”), which are defined as
measures whose purpose it is to protect animal, plant, or human health
These risks
against certain risks associated with foreign goods.12
include, among others, risks caused by toxins, diseases, and pests.13
Since recent studies show that certain nanoparticles are toxic to fish,14
the purpose of some measures regulating trade in nanotechnology will be
to protect animal, plant, or human health against such risks. In as much
as they do, such measures would be subject to the SPS Agreement.
¶5
In showing whether the SPS Agreement applies to
nanotechnology, it is important to first define what nanotechnology is.
This iBrief then considers the current state of nanotechnology and the
different organizations that set international standards for this emerging
field. It then looks at the relevant trade law and how this law applies to
nanotechnology. The WTO Appellate Body decision in Hormone Beef
has strengthened the requirement that SPS measures must be based on
scientific evidence.15 Accordingly, this iBrief concludes that if Members
apply the SPS Agreement appropriately, the Agreement would
objectively balance the benefits and risks of trading in nanotechnology.

I. NANOTECHNOLOGY
A. Its Origins
¶6
Nano means “extremely small” or “one-billionth” and is derived
from the Greek word “nanos” meaning little old man or dwarf.16 In
1986, K. Eric Drexler coined the term nanotechnology in his book
Engines of Creation: the Coming Era of Nanotechnology. 17 In the
glossary of the book, Drexler defines nanotechnology as “[t]echnology
based on the manipulation of individual atoms and molecules to build
In explaining
structures to complex, atomic specifications.”18
nanotechnology, Drexler described an idea first expressed by renowned
physicist Richard Feynman in his now classic 1959 address entitled
There’s Plenty of Room at the Bottom.19 In the address, Feynman
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NANOTECHNOLOGY (4th ed. 1994), available at
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discussed the possibility of manipulating matter on the smallest scale, or
the ability to artificially create at the atomic level - much like cells have
been doing since life began:
The principles of physics, as far as I can see, do not speak against
the possibility of maneuvering things atom by atom . . . It would be,
in principle, possible . . . for a physicist to synthesize any chemical
substance that the chemist writes down. . . . How? Put the atoms
down where the chemist says, and so you make the substance. The
problems of chemistry and biology can be greatly helped if our
ability to see what we are doing, and to do things on an atomic
level, is ultimately developed - a development which I think cannot
be avoided.20
¶7
If possible, Feynman’s idea would mean nations with this
capability could build practically anything, molecule-by-molecule. In
addition, some believe that this development could eventually lead to the
end of the world: uncontrollable self-replicating nano sized robots would
turn the earth into “gray goo.” Drexler described one version of the
“gray goo” concern where nano plants “with ‘leaves’ no more efficient
than today’s solar cells could out-compete real plants, crowding the
biosphere with an inedible foliage.”21
¶8
Despite Drexler’s use of nanotechnology to express Feynman’s
original idea, the term nanotechnology now “embraces a broad range of
science and technology working at a length scale approximately 1 to 100
nanometers, including the more specific goal [of molecular
manufacturing] it originally denoted.”22

B. Current Developments
¶9
There are also at least 30 different countries developing
initiatives to promote and exploit nanotechnologies.23 For example, in
2003 Congress passed the 21st Century Nanotechnology Research and
Development Act.24 This Act created the National Nanotechnology
Initiative (“NNI”), and the Act provides $3.7 billion25 for the next three
years for the NNI to “coordinate the multiagency effort in nanoscale

ENGINEERING AND SCIENCE (Dec. 1959), available at
http://www.its.caltech.edu/~feynman/plenty.html (last visited May 10, 2005).
20
Engines of Creation, supra note 17, at 215.
21
Id.
22
Drexler, supra note 2.
23
M.C. Roco, Government Nanotechnology Funding: An International Outlook,
National Science Foundation (June 30, 2003), at
http://www.nano.gov/html/res/IntlFundingRoco.htm.
24
21st Century Nanotechnology Research and Development Act, Pub. L. No.
108-153 (S. 189), §§ 1-10 (2003) (codified at 15 U.S.C. §§ 7501-09).
25
Id. (§ 6 appropriations add up to approx. $3.7 billion).
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science, engineering and technology.”26 In addition to the NNI, there are
at least 52 different nanotechnology research and education centers
throughout the United States.27
Although most U.S. and foreign nanotechnology initiatives are
created to study the commercial uses of nanotechnology, some groups
are realizing the need to study the potential health risks, as well. For
example, the Environmental Protection Agency (“EPA”) recently gave
$4 million to 12 different universities to study the potential
environmental and health risks of nanomaterials.28 In its announcement,
the EPA said that there is currently “very limited scientific information
on the effects of nanomaterials on human health and the environment.”29
¶10

¶11
Toxicologist Dr. Eva Oberdörster has provided important
contributions to this limited set of scientific information with studies
showing that certain nanoparticles are harmful to forms of aquatic life.30
One study showed that modest concentrations of fullerenes, synthetic,
soccer ball-like, nanosized carbon molecules, in water eventually killed
water fleas.31 Another Oberdörster’s study showed that fullerenes caused
brain damage in largemouth bass.32 This study led Oberdörster to
believe that the nanoparticles may have also killed beneficial bacteria in
the water where the fish were tested.33 Oberdörster’s research is unique
because it is the first research to examine the possible effects of releasing
synthetic nanoparticles into the environment.34 Other studies have also
shown that nanoparticles have toxic effects on living matter: for
example, in 2003, researchers found that nanotubes, a specific type of
nanoparticle, damaged lung tissue in mice.35
¶12
In light of these studies, some industries have urged scientists
and policy makers to proceed with caution on the quest for harnessing

26

NNI, About the NNI, at http://www.nano.gov/html/about/home_about.html
(last visited Mar. 19, 2005).
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Research Environmental Impact of Nanotechnology (Nov. 12, 2004), at
http://www.epa.gov/cgi-bin/epaprintonly.cgi. Fullerenes are often called
“buckyballs” because they look like the “famous geodesic dome of R.
Buckminster Fuller, the visionary architect and scientist.” Gills, supra note 5.
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Id.
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Id. at 1059-61.
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Id.
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Id. at 1059.
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Id.
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Bob Holmes, Buckyballs Cause Brain Damage in Fish, NEW SCIENTIST (Mar.
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nanotechnology.36 In May 2004, Swiss Re, one of the world’s largest
insurance companies, published a report on the risks of nanotechnology
containing a list of potential issues that it thought needed to be addressed
before significant developments in nanotechnology should continue.37
However, in July 2004, a report38 commissioned by the United Kingdom
concluded that many new nano-sciences and -technologies do not present
unique risks to health, safety or the environment.39
¶13
Whether such reports are taken into consideration in establishing
U.S. nanotechnology policy depends on a number of federal agencies.
The U.S. Department of Agriculture (“USDA”) works with the three
main international bodies responsible for setting standards relating to the
SPS Agreement: (1) the Codex Alimentarius Commission, responsible
for food safety;40 (2) the Office Internationale des Epizooties, responsible
for animal health;41 and (3) the Secretariat of the International Plant
Protection Convention, responsible for plant health.42 The USDA’s U.S.
Codex Office of the Food Safety and Inspection Service (“FSIS”)
coordinates U.S. relations with the Codex Alimentarius Commission.43
The FSIS is the public health agency of the USDA,44 and is responsible
for ensuring that the United States’ commercial supply of meat, poultry,
and egg products is safe and correctly packaged and labeled.45
¶14
The Animal and Plant Health Inspection Service (“APHIS”) of
the USDA is responsible for coordination with the Secretariat of the
International Plant Protection Convention and the Office Internationale

36

SWISS RE, NANOTECHNOLOGY - SMALL MATTER, MANY UNKNOWNS (May
2004), http://www.swissre.com/internet/pwswpspr.nsf/alldocbyidkeylu/ulur5yaffs.
37
Id.
38
THE ROYAL SOCIETY AND THE ROYAL ACADEMY OF ENGINEERING,
NANOSCIENCE AND NANOTECHNOLOGIES: OPPORTUNITIES AND UNCERTAINTIES
(July 29, 2004), at http://www.nanotec.org.uk/finalReport.htm.
39
Id. at para. 8.1.3, http://www.nanotec.org.uk/report/chapter8.pdf.
40
Codex Amlimentarius Commission, at
http://www.codexalimentarius.net/web/index_en.jsp (last visited April 6, 2005).
41
Office Internationale des Epizooties, What is OIE?, at
http://www.oie.int/eng/OIE/en_oie.htm (last visited April 6, 2005).
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See International Phytosanitary Portal, at
https://www.ippc.int/IPP/En/default.jsp (last visited April 6, 2005).
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FOOD SAFETY AND INSPECTION SERVICE, Regulations and Policies,
International Affairs, Codex Alimentarius, at
http://www.fsis.usda.gov/Regulations_&_Policies/Codex_Alimentarius/index.as
p (last visited Mar. 19, 2005).
44
FOOD SAFETY AND INSPECTION SERVICE, About FSIS, at
http://www.fsis.usda.gov/About_FSIS/index.asp (last visited Mar. 19, 2005).
45
Id.
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des Epizooties.46 The APHIS assesses and regulates the risks associated
with agricultural imports.47

II. APPLICABLE LAWS
¶15
In 1947, several countries enacted the General Agreement on
Tariffs and Trade (“GATT”) to reduce tariffs and increase world trade.48
On January 1, 1995, the World Trade Organization (“WTO”) replaced
the GATT as the organization overseeing the “multilateral trading
system.”49 While the GATT has been very successful in reducing tariff
barriers,50 the practical effect of the GATT has been lessened because its
Members have resorted to non-tariff trade barriers to skirt their
obligations. For example, Article XX of the GATT allows for protective
measures that protect human, animal, or plant health has been widely
exploited.51 Ironically, these same Members created the SPS Agreement
to reduce such non-tariff barriers to trade.52

A. The SPS Agreement
¶16
The SPS Agreement has two main goals: (1) allowing Members
to maintain the level of health protection they consider appropriate; and
(2) ensuring that sanitary and phytosanitary (“SPS”) measures are not
unnecessary, arbitrary, or scientifically unjustifiable.53 To achieve these
objectives the SPS Agreement only applies to SPS measures, and
requires that SPS measures that are not following international standards
conduct a risk assessment that is rationally related to scientific evidence.

46

ANIMAL AND PLANT HEALTH INSPECTION SERVICE, Overview, International
Services, at http://www.aphis.usda.gov/is/pages/overview.htm (last visited April
6, 2005).
47
See id.
48
See WTO, SPS Agreement Training Module: Introduction to the SPS
Agreement, at
http://www.wto.org/english/tratop_e/sps_e/sps_agreement_cbt_e/c1s1p1_e.htm
[hereinafter SPS Introduction] (last visited April 6, 2005).
49
WTO, http://www.wto.org/english/thewto_e/gattmem_e.htm (last visited May
9, 2005). Most of the GATT’s substantive provisions were incorporated into the
WTO.
50
See World Trade Organization, The WTO in Brief, at
http://www.wto.org/english/thewto_e/whatis_e/inbrief_e/inbr01_e.htm (last
visited April 6, 2005).
51
General Agreement on Tariffs and Trade, Oct. 30, 1947 [hereinafter
“GATT”], art. XX (1994).
52
See World Trade Organization, SPS Agreement Training Module:
Background, at
http://www.wto.org/english/tratop_e/sps_e/sps_agreement_cbt_e/intro1_e.htm
(last visited April 6, 2005).
53
SPS Introduction, supra note 48.
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Lastly, the Agreement allows for countries to take temporary
precautionary measures in the face of uncertain risk.
1. Scope
¶17
The SPS Agreement applies only to WTO Members. Moreover,
it states in its first article that the agreement applies to “all sanitary and
phytosanitary measures which may, directly or indirectly, affect
international trade.”54 Considering the global economy, the requirement
that these measures affect international trade is in practice not difficult to
satisfy. This analysis assumes that this requirement is met. The more
difficult question is what constitutes a sanitary or phytosanitary measure.
According to Annex A1 of the SPS Agreement, whether a measure
prohibiting trade is a sanitary or phytosanitary measure depends on its
purpose.55 Annex A1 specifically mentions four purposes that satisfy
this requirement:
(a) to protect animal or plant life or health . . . from risks arising
from . . . pests, diseases, disease-carrying organisms or diseasecausing organisms;
(b) to protect human or animal life or health . . . from risks arising
from additives, contaminants, toxins or disease-causing organisms
in foods, beverages or feedstuffs;
(c) to protect human life or health . . . from risks arising from
diseases carried by animals, plants or products thereof, or from the
entry, establishment or spread of pests; or
(d) to prevent or limit other damage . . . from the entry,
establishment or spread of pests. 56

The form of the measure is not important in determining whether it is a
SPS measure.57 For example, SPS measures include even technical
measures, such as labeling requirements, if they are created to protect
human life from the risks arising from toxins.58
¶18
Few Appellate Body decisions and panel reports discuss the
scope of the SPS Agreement. In Australia – Measures Affecting
Importation of Salmon (“Australia – Salmon”), however, a WTO
panel examined whether an Australian prohibition on imports of dead
54

SPS Agreement, supra note 9, art. 1.1.
Id. Annex A1.
56
Id.
57
WTO, SPS Agreement Training Module: Introduction to the SPS Agreement,
1.4 SPS and TBT measures, at
http://www.wto.org/english/tratop_e/sps_e/sps_agreement_cbt_e/c1s4p1_e.htm
(last visited April 6, 2005).
58
Id.
55

2005

DUKE LAW & TECHNOLOGY REVIEW

No. 15

salmon was a “sanitary measure” within the meaning of paragraph 1(a)
and (b) of Annex A1 of the SPS Agreement.59 The panel found that
Australia’s prohibition was within the scope of the SPS Agreement under
paragraph 1(a) because the purpose of the measure was to protect
Australia’s fish from exotic disease.60 Once it is found that the SPS
Agreement applies to a specific measure, whether the measure is based
on scientific evidence or an international standard must be determined.
2. Scientific evidence and the risk assessment
¶19
If an SPS measure is not based on an international standard, the
Member must show it is based on a risk assessment.61 A risk assessment
requires that Members “ensure that their sanitary or phytosanitary
measures are based on an assessment, as appropriate to the
circumstances, of the risks to human, animal or plant life or health,
taking into account risk assessment techniques developed by the relevant
international organizations.”62 It further requires that Members take
available scientific evidence into account.63 In Hormone Beef, the WTO
Appellate Body determined that Article 2.2 of the SPS Agreement
informs Article 5.1.64 Article 2.2 requires that SPS measures be based on
scientific principles and maintained with sufficient scientific evidence,
while Article 5.1 requires that Members ensure their SPS measures are
based on a risk assessment.65 The Appellate Body found further that
Article 2.3 informs Article 5.5. Article 2.3 requires that SPS measures
do not unjustifiably discriminate between Members and that they are not
applied in a way that would constitute a disguised restriction on trade,
and Article 5.5 requires that Members avoid arbitrary and unjustifiable
distinctions in SPS protection levels for different situations.66 These
findings solidify the importance of scientific evidence as a requirement
of the SPS Agreement when measures are not based on international
standards.
3. Harmonization with international standards
¶20
With few exceptions, the SPS Agreement requires Members to
base SPS measures on existing international standards. The SPS
Agreement explicitly recognizes the standards set by the three
59

Australia – Measures Affecting Importation of Salmon, Recourse to Article
21.5 by Canada, WT/DS18/RW [hereinafter Australia – Salmon] (Feb. 18,
2000), available at http://www.worldtradelaw.net/reports/wtopanels/australiasalmon(panel)(21.5).pdf.
60
See id. para. 2.3.
61
SPS Agreement, supra note 9, art. 5.1.
62
Id.
63
Id. art. 5.2.
64
Hormone Beef, supra note 10, paras. 180-81.
65
Id.
66
Id. para. 250.
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international standard setting bodies mentioned above: (1) the Codex
Alimentarious Commission, for food safety; (2) the Office Internationale
des Epizooties, for animal health; and (3) the Secretariat of the
International Plant Protection Convention, for plant health.67 The
WTO’s SPS Committee oversees harmonization of domestic measures
with international standards by working directly with these three
bodies.68
4. Precaution and the precautionary principle
Article 5.7 of the SPS Agreement allows Members to use some
precaution when enacting SPS measures.69 Specifically, it permits
countries to adopt provisional SPS measures in cases where relevant
scientific evidence is not sufficient to establish the safety or threat of a
good.70 These provisional measures must be based on available pertinent
information.71 This information includes that from relevant international
organizations and from SPS measures applied by other Members.72 In
such circumstances, Members must seek to obtain the additional
information necessary for a more objective assessment of risk and review
the SPS measure accordingly within a reasonable time.73 Provisional
measures are permitted only until sufficient evidence is available to
either justify or condemn the measures.
¶21

B. Other WTO Disputes
¶22
Members have only brought a few disputes before the WTO
regarding the SPS Agreement. The most important dispute, Hormone
Beef, was brought by the United States and Canada against the European
Communities challenging the E.C.’s ban on the importation of hormone
treated beef. The WTO Appellate Body found that the E.C.’s measures
prohibiting the importation of hormone treated beef were in violation of
Article 5.1 of the SPS Agreement because they were not rationally
related to a risk assessment.74 Although the original panel was requested
to hear the dispute in 1996 and the Appellate Body’s report was adopted
in 1998, the European Communities still has not complied with the

67

SPS Agreement, supra note 9, art. 3.
See id. art. 3.5.
69
See id. art. 5.7.
70
See id.
71
Id.
72
Id.
73
Id.
74
Hormone Beef, supra note 10, paras. 208-209.
68
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After almost 10 years, the dispute is still

¶23
Another WTO dispute dealing with the SPS Agreement is Japan
– Measures Affecting Agricultural Products (“Japan – Agricultural

Products”).77 There, the Appellate Body identified four requirements
Members must meet to comply with Article 5.7.78 Members may
provisionally adopt an SPS measure if the measure is (1) imposed in
response to insufficient scientific information; and (2) adopted “on the
basis of available pertinent information.” After imposing provisional
measures, Members must also (3) seek additional information necessary
for a more objective risk assessment; and (4) review the measure within a
reasonable period of time.79 The Appellate Body stated further that
“Article 5.7 operates as a qualified exemption from the obligation under
Article 2.2 not to maintain SPS measures without sufficient scientific
evidence. An overly broad and flexible interpretation of that obligation
would render Article 5.7 meaningless.”80
¶24
The most recent WTO dispute alleging violations of the SPS
Agreement is European Communities – Measures Affecting the
Approval and Marketing of Biotech Products (“EC – Biotech
Products”).81 The WTO has not yet released a panel report regarding
this dispute. Here, the United States alleges the E.C. moratorium on the
approval of products of agricultural biotechnology (“biotech products”)
violates, among other agreements, the SPS Agreement. Specifically, the
U.S. alleges that the E.C. moratorium imposes an undue delay to its
biotech procedures. Furthermore, many of the products “caught up in the
E.C. moratorium have been positively assessed by the E.C.’s own
scientific committees.”82 Since the WTO has not yet issued a report on
75

See Bridges: Weekly Trade New Digest, EC beef hormone dispute drags on
(Nov. 13, 2003), at http://www.ictsd.org/weekly/03-11-13/story3.htm.
76
Id.
77
Japan – Measures Affecting Agricultural Products WT/DS76/AB/R (Feb. 22,
1999) [hereinafter Japan – Agricultural], available at
http://www.worldtradelaw.net/reports/wtoab/japan-agproducts(ab).pdf.
78
WTO, Analytical Index, SPS Agreement, art. 5.7, para. 115, available at
http://www.wto.org/english/res_e/booksp_e/analytic_index_e/sps_02_e.htm#arti
cle5B6 (last visited Mar. 19, 2005).
79
Japan – Agricultural, supra note 77, para. 89.
80
Id. para. 80.
81
European Communities – Measures Affecting the Approval and Marketing of
Biotech Products WT/DS291/23, Request for the Establishment of a Panel by
the United States (Aug. 8, 2003), available at
http://www.worldtradelaw.net/pr/ds291-23(pr).pdf.
82
European Communities – Measures Affecting the Approval and Marketing of
Biotech Products WT/DS291, 292, and 293, Executive Summary of the First
Submission of the United States, para. 4 (April 30, 2004), available at
http://www.ustr.gov/assets/Trade_Agreements/Monitoring_Enforcement/Disput
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this issue, it is less relevant to the discussion of nanotechnology and the
SPS Agreement than other WTO disputes.

III. THE SPS AGREEMENT AND NANOTECHNOLOGY
A. Would the SPS Agreement apply to measures regulating trade in
nanotechnology?
¶25
Whether the SPS Agreement applies to measures regulating trade
in nanotechnology ultimately depends on the purpose of the specific
measures. The SPS Agreement applies to all “sanitary and phytosanitary
measures which may, directly or indirectly, affect international trade.”83
Assuming measures regulating trade in nanotechnology affect
international trade, they are subject to the SPS Agreement if they are SPS
measures. They are SPS measures if they have any of the four purposes
identified in Annex A1 of the SPS Agreement, discussed in section IIA
above. The first three provisions generally have two requirements: to
protect different kinds of life from various health risks. The fourth
category seeks to prevent damage by pests.
¶26
Given Dr. Oberdörfer’s studies showing the toxicity of some
nanoparticles to fish, it is easy to imagine measures regulating
nanotechnology with the purpose of protecting animal or human life
from toxins in foods, beverages or feedstuffs. Such measures would
satisfy the requirements of category (b) above and, therefore, be subject
to the SPS Agreement. Moreover, the first question of whether such
measures would have the requisite purpose of protecting animal or
human life is an abstract question because we do not have specific
measures to analyze. However, as shown by Hormone Beef and
Australia - Salmon, the purpose of protective measures is generally not
disputed. That is, if a Member says the purpose of a measure is to
protect or fish from diseases, this assertion is generally not challenged.
The second question, whether nanotechnology is a toxin, is also not
difficult to answer. Considering Dr. Oberdörfer’s studies, it is hard to
imagine that measures prohibiting the trade of fullerenes would not
satisfy this category. Oberdörfer has shown that fullerenes are toxic to
large mouth bass.84
¶27
Other provisions of Annex 1A present more difficult questions.
For example, category (a) includes any measure with the purpose of

e_Settlement/WTO/Dispute_Settlement_Listings/asset_upload_file737_5542.pd
f.
83
SPS Agreement, supra note 9, art. 1.1.
84
However, a similar measure regulating the trade of all nanotechnology might
not be so easily justifiable. Are all nanotechnologies toxic to human or animal
life? Such factual questions, although important, are beyond the scope of this
iBrief.
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protecting animal or plant life or health from risks from pests or diseases,
including disease -carrying or-causing organisms. Are nanoparticles
pests? Are they diseases? Or, do they cause disease and, thus, also
satisfy the requirement? What about measures that regulate the trade in a
different type of nanotechnology? For example, Drexler’s example of
the gray goo problem sounds a lot like a pest: “‘Plants’ with ‘leaves’ no
more efficient than today’s solar cells could out-compete real plants,
crowding the biosphere with an inedible foliage.”85 Category (d) also
raises the question of whether nanotechnology is a pest.
¶28
In addition, category (c) encompasses any measure whose
purpose it is to protect humans from the risks of diseases carried by
animals, plants or products thereof, or from pests. This again raises
some of the same questions mentioned above: are nanoparticles diseases,
or do they cause disease? What about nanotechnology as a whole? If
nanoparticles are not themselves considered toxins but cause diseases,
measures regulating their trade would be subject to the SPS Agreement.
To answer these questions one must examine the nature of the specific
nanotechnology in question. Moreover, in the case of nanoparticles,
specifically fullerenes, these questions may be avoided by looking at the
ostensibly more straightforward questions presented by category (b) of
Annex A1.
¶29
WTO jurisprudence provides little help in determining whether
nanotechnology or nanoparticles are pests, diseases, disease-carrying
organisms or disease-causing organisms. The only WTO ruling that
expounds Annex A1 is Australia - Salmon. There, Australia banned the
importation of fresh, chilled or frozen salmon that had not been heat
treated to protect against 24 known disease agents.86 The panel
implicitly acknowledged without discussion that the measure was subject
to the SPS Agreement. The only discussion was directed towards
determining which provision of Annex A1 covered the measure. The
panel found that because of “the objectives for which the measure is
being applied,” it was a “‘sanitary measure’” under the definition of
paragraph 1(a) of Annex A1.87 The panel ruling reinforces the language
of Annex A1 stating that any measure whose objective is to protect
humans, animals, or plants from the risks specified in the SPS
Agreement is considered an SPS measure and subject to the SPS
Agreement.
¶30
Hormone Beef also sheds some light on the question. There, the
European Communities banned the importation of meat and meat
85

Engines of Creation, supra note 17, at 215.
Australia - Measures Affecting Importation of Salmon, WT/DS18/R, paras.
1.1 & 2.11 (June 12, 1998), available at
http://www.worldtradelaw.net/reports/wtopanels/australia-salmon(panel).pdf.
87
Id. para. 8.34.
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products from cattle treated with any of six specific hormones for growth
purposes. The explicit purpose of these measures was to protect human
health. Both parties agreed that the measures were subject to the SPS
Agreement according to Paragraph 1(b) of Annex A: “ ‘any measure
applied to protect human . . . health . . . from risks arising from additives,
contaminants, toxins or disease-causing organisms in food, beverages or
feedstuffs.’”88 The panel agreed with the parties. It said the E.C.
measures were applied to protect human life or health from risks arising
from contaminants, “namely residues of six specific hormones, in
foods.”89 The panel noted that footnote 4 to Annex A specified that
“contaminants” includes “pesticide and veterinary drug residues and
extraneous matter.” The panel concluded that “[s]ince the six hormones
in dispute are veterinary drugs, the parties agree that the alleged risks at
issue arise from contaminants.”90
¶31
Considering recent scientific evidence, measures that regulated
the trade in nanotechnology with the purpose of protecting human or
animal life from toxins would be subject to the SPS Agreement.

B. Would the SPS Agreement provide an objective balance between
the risks and benefits of trading in nanotechnologies?91
¶32
Because the SPS Agreement requires Members to base their SPS
measures on scientific evidence, the Agreement would provide an
objective balance between the risks and benefits of trading in
nanotechnology.92 According to Article 2.2, Members must ensure that
their SPS measures are “based on scientific principles and [are] not
In addition,
maintained without sufficient scientific evidence.”93
Members must ensure their SPS measures “do not arbitrarily or
unjustifiably discriminate between Members,” and that their SPS

88

EC Measures Concerning Meat and Meat Products (Hormones) Complaint by
the United States Report of the Panel WT/DS26/R/USA, para. 8.21 (Aug. 18,
1997) [hereinafter Hormone Beef Complaint], available at
http://www.worldtradelaw.net/reports/wtopanels/ec-hormones(panel)(us).pdf.
89
Id. para. 8.22.
90
Id. para. 8.21.
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In practice, the answer to this question depends on how individual Members
interpret the obligations created by the SPS Agreement. For example, in
Hormone Beef, the European Communities dismissed the SPS Agreement’s
requirement to base SPS measures on scientific evidence. They disagreed with
the United States and the WTO Appellate Body on how precaution should play a
role in the risk assessment. For the SPS Agreement to objectively regulated
trade in nanotechnologies, the European Communities and the United States
need to reconcile their differences regarding the role of precaution under the
SPS Agreement.
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measures are not applied in a manner that would constitute a disguised
restriction on trade.94 Although this article has not been adjudicated at
the WTO, the Appellate Body in Hormone Beef held that Article 2.3 is
part of the risk assessment of Article 5.5.95 Article 2.3 play an important
role in future WTO disputes.
¶33
In the case of nanoparticles, especially fullerenes, it seems that
preliminary measures under Article 5.7 could be based on scientific
evidence, specifically the Oberdörster study. In light of how long it took
the international community to effectively regulate asbestos it would
seem that protective measures regulating the trade in potentially harmful
nanoparticles would be welcome.

CONCLUSION
¶34
Nanotechnology is becoming more important each day. This
includes both the development of and trade in goods containing
nanoparticles and the progress made towards the specific goal of
molecular manufacturing. Although such developments bring immediate
benefits to consumers and investors in the form of, for example, longer
lasting tennis balls and loftier golf balls, they also bring significant risks.
In light of these risks, nations will inevitably establish measures that
regulate the trade in nanotechnology. Considering recent scientific
evidence, measures that regulated the trade in nanotechnology with the
purpose of protecting human or animal life from toxins would be subject
to the SPS Agreement. If this is the case, the agreement’s reliance on
scientific evidence would provide for an objective balance between the
risks and benefits in trading in nanotechnology.

94
95

Id. art. 2.3.
Hormone Beef, supra note 10, paras. 180-81.

